本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

17.79
+0.07000.40%
成交量:24.51萬
成交額:435.82萬
市值:22.74億
市盈率:103.19
高:17.98
開:17.62
低:17.48
收:17.72
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.25
換手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.14
市盈率(LYR):103.19

資料載入中...

2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities